Sunil Mehra joined Abbott on June 30, 2020 as General Manager for Abbott Rapid Diagnostics - IDEM, India.
He is a seasoned professional with 26 years’ experience across businesses and countries from Sales, Marketing, Innovations and R&D with a successful track record. He has completed his Masters in Business Administration from Faculty of Management Studies, University of Delhi and also has a Masters and Bachelors degree in Pharmaceutical Sciences from BITS, Pilani.
As part of Abbott Rapid Diagnostics team, Sunil is a crucial member of Abbott's COVID-19 taskforce and has good knowledge on how to handle covid outbreaks in India. Prior to joining Abbott, Sunil was associated with Glaxo SmithKline Consumer Healthcare in various leadership roles for the last 23 years. His last role at GSK was as General Manager – Sri Lanka & Maldives. He was the Chairman/Managing Director of the GSK Sri Lanka Legal entity and lead the P&L responsibility with a 400 member team. Sunil started his career with Ranbaxy Research Laboratories and was with them for 3 years.
Sunil is a strong people’s person with ability to create organizational structures and driving these to create a culture of winning by focusing on talent development & people processes and motivating the teams to achieve stretch targets.
He has successfully handled holistic integration of acquisitions and has built corporate image through high impact partnership with Government and other Industry bodies.